Jonathan Sebat is professor of psychiatry and cellular and molecular medicine at the University of California, San Diego, and chief of the Beyster Center for Molecular Genomics of Neuropsychiatric Diseases. He investigates the molecular basis of neuropsychiatric disorders such as autism and schizophrenia.
Jonathan Sebat
Professor
University of California, San Diego
From this contributor
Why I want to march for science
Autism researcher Jonathan Sebat plans to push for policies that rest on empirical evidence and serve the common good.
Explore more from The Transmitter
Novel assembloid illuminates serotonin changes linked to 22q11.2 deletion
The combination of a serotonin-producing organoid with an organoid based on the developing cerebral cortex offers a new way to investigate neuromodulation.
Novel assembloid illuminates serotonin changes linked to 22q11.2 deletion
The combination of a serotonin-producing organoid with an organoid based on the developing cerebral cortex offers a new way to investigate neuromodulation.
By
Sarah DeWeerdt
30 April 2026 | 0 min watch
Reporter’s notebook: Highlights from INSAR 2026
At the 25th annual meeting of the International Society for Autism Research, scientists, clinicians and self-advocates gathered to discuss topics such as autism genetics and the gap between clinical trials and real-world benefits.
Reporter’s notebook: Highlights from INSAR 2026
At the 25th annual meeting of the International Society for Autism Research, scientists, clinicians and self-advocates gathered to discuss topics such as autism genetics and the gap between clinical trials and real-world benefits.
By
Diana Kwon
30 April 2026 | 6 min read
Scientists push back against stricter European Research Council grant application rules
In an open letter, scientists call the ERC’s suggestion to block grant reapplications for an additional year “at odds with scientific excellence.”
Scientists push back against stricter European Research Council grant application rules
In an open letter, scientists call the ERC’s suggestion to block grant reapplications for an additional year “at odds with scientific excellence.”
By
Lauren Schenkman
29 April 2026 | 5 min read